CD55 Recombinant Antibody, Cy7 Conjugated
Product Specifications
Background
This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade
Synonyms
Cd55a; Complement decay accelerating factor; CROM; DAF; Daf-GPI; Daf1; GPI-DAF.
Gene ID
1604
Swiss Prot
P08174
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
CD55
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human CD55
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1604
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H1827-01-FITC 100 µL
HCLS1 (Hematopoietic Cell-Specific Lyn Substrate 1) (FITC) discontinued
Ask
View Details 
